Human Polo-like Kinase Inhibitors as Antiplasmodials.
Sign Up to like & getrecommendations! Published in 2023 at "ACS infectious diseases"
DOI: 10.1021/acsinfecdis.3c00025
Abstract: Protein kinases have proven to be a very productive class of therapeutic targets, and over 90 inhibitors are currently in clinical use primarily for the treatment of cancer. Repurposing these inhibitors as antimalarials could provide… read more here.
Keywords: polo like; human polo; like kinase; kinase inhibitors ... See more keywords